Efficacy and safety profile of Glucagon-Like Peptide-1 Receptor Agonist in obese Type-2 diabetes patients from a private institution in Karachi
| Autor: | Saeeda Fouzia Qasim, Tasnim Ahsan, Saima Ghaus, Paras Imran |
|---|---|
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Pakistan Journal of Medical Sciences. 39 |
| ISSN: | 1681-715X 1682-024X |
| Popis: | Objective: To assess the effectiveness of GLP-1RAs in managing obese T2DM patients. Methods: This prospective cohort analysis was conducted at Medicell Institute of Diabetes, Karachi, Pakistan; from July 2019 to July 2021. A total of 97 obese individuals >16 years of age with T2DM and IGT were initially enrolled, and 81 patients who showed up for the follow-up were prescribed one of the three GLP-1RAs available in Pakistan. Results: Out of 81 patients who showed up for the follow-up visit, 43 had received Liraglutide, 25 were taking Dulaglutide, and 13 had been prescribed IDegLira supplemented with oral hypoglycemic medications ± insulin. The mean age of the enrolled patients was 49.21(12.44) years, and there was female predominance (55.6%). Overall, there was a significant weight and BMI reduction among the patients treated with either of the GLP-1RAs (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|